| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83341 |
5-羧基荧光素标记A20FMDV2-Gd-DOTA |
151 |
h |
2024-12-18 |
| 83342 |
竹节参皂苷Ⅳa脑靶向脂质体,C-Ⅳa-LPs,载药脂质体定制服务 |
149 |
axc |
2024-12-18 |
| 83343 |
cas:2249935-92-8，Mal-PEG1-Val-Cit-PAB-PNP，马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-PNP 酯 |
140 |
kx |
2024-12-18 |
| 83344 |
VG-PEG24-Chol 24单位PEG接头偶联胆固醇多肽 |
180 |
zyl |
2024-12-18 |
| 83345 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭环辛烯衍生物二苄基环辛烯 |
126 |
h |
2024-12-18 |
| 83346 |
CAS: 330970-70-2 Alloc-Val-Ala-OH，N-Alloc-L-valyl-L-alanine 或 (S)-2-((S)-2-(Allyloxycarbonylamino)-3-methylbutanamido)propanoic acid |
103 |
WYQ |
2024-12-18 |
| 83347 |
3-[(2-氨基乙基)二硫]丙酸，Aminoethyl-SS-propionic acid，ADC定制 |
146 |
wyh |
2024-12-18 |
| 83348 |
负载槲皮素与多柔比星的脂质体,QUE-DOX--Lips,靶向脂质体定制服务 |
195 |
axc |
2024-12-18 |
| 83349 |
DOTA-siRNA 螯合剂DOTA偶联siRNA纳米颗粒 |
158 |
h |
2024-12-18 |
| 83350 |
cFLFLFK-PEG12-Cy3的介绍 |
144 |
zyl |
2024-12-18 |
| 83351 |
DOTA-E{PEG4-E[Gly3-c(RGDfK)]2}2 |
142 |
h |
2024-12-18 |
| 83352 |
RGD修饰的共载姜黄素和阿霉素脂质体,cRGD-(C+D/LP)，提供荧光脂质体定制服务 |
171 |
axc |
2024-12-18 |
| 83353 |
螯合剂DOTA-NHS |
127 |
h |
2024-12-18 |
| 83354 |
Mal-PEG2-Val-Ala-PAB-PNP，马来酰亚胺-二聚乙二醇-VAL-ALA-PAB-PNP 酯 |
136 |
kx |
2024-12-18 |
| 83355 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)螯合物偶联配体[SHALs]) |
182 |
h |
2024-12-18 |
| 83356 |
DOTA(Gd))-b-PCL DOTA(Gd)螯合物修饰聚己内酯聚合物胶束 |
121 |
h |
2024-12-18 |
| 83357 |
土贝母苷甲脂质体，Tub,I-LPs，载药脂质体定制服务 |
111 |
axc |
2024-12-18 |
| 83358 |
半乳糖-RGD2 Galacto-RGD2 |
141 |
h |
2024-12-18 |
| 83359 |
DOTA-dPEG2-R954 DOTA偶联B1R拮抗剂R954 |
111 |
h |
2024-12-18 |
| 83360 |
竹节参皂苷Ⅳa脑靶向脂质体，脂质体纳米载体定制服务 |
159 |
axc |
2024-12-18 |
| 83361 |
cas:253863-34-2，Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP，ADC定制 |
108 |
wyh |
2024-12-18 |
| 83362 |
CAS: 1343407-91-9 Alloc-Val-Ala-PAB（或Val-Ala-PAB-OH） |
122 |
WYQ |
2024-12-18 |
| 83363 |
DOTA-PEG-NH2 DOTA-聚乙二醇-氨基 |
141 |
h |
2024-12-18 |
| 83364 |
R-8PEG-4PCL的介绍 |
126 |
zyl |
2024-12-18 |
| 83365 |
N3-tri-EG-OPFP，ADC定制 |
103 |
wyh |
2024-12-18 |
| 83366 |
cas:1949793-41-2， Mal-amido-PEG4-Val-Cit-PAB-OH，马来酰亚胺-四聚乙二醇-VAL-CIT-PAB |
116 |
kx |
2024-12-18 |
| 83367 |
甘露糖修饰脂质体包装ASFV,CP204L基因,多功能载药脂质体定制服务 |
128 |
axc |
2024-12-18 |
| 83368 |
DOTA-βA-NH2 |
118 |
h |
2024-12-18 |
| 83369 |
Py-ds-dmBut-OPFP，2101206-44-2，ADC定制 |
124 |
wyh |
2024-12-18 |
| 83370 |
ALD-di-EG-OPFP，ADC定制 |
116 |
wyh |
2024-12-18 |
| 83371 |
cas:2055047-18-0，Azido-PEG3-Val-Cit-PAB-PNP，叠氮-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
92 |
kx |
2024-12-18 |
| 83372 |
柠檬草精油脂质体,LONL,载药脂质体定制服务 |
158 |
axc |
2024-12-18 |
| 83373 |
cas:159857-79-1，Val-cit-PAB-OH，ADC定制 |
125 |
wyh |
2024-12-18 |
| 83374 |
双载IR780与HCQ的温敏脂质体（IR780/HCQ-Lip） |
155 |
axc |
2024-12-18 |
| 83375 |
endo BCN-PEG3-Val-Cit，(1R,8S,9S)-双环[6.1.0]壬-三聚乙二醇-VAL-CIT |
103 |
kx |
2024-12-18 |
| 83376 |
DOTA-(PEG28)2-A20FMDV2 双末端聚乙二醇化的A20FMDV2偶联DOTA大环配体 |
127 |
h |
2024-12-18 |
| 83377 |
PEG2K-Hyd-PEI聚合物包裹共载SS31肽和胰岛素的脂质体纳米粒,PHP-DPS@INS,NPs |
165 |
axc |
2024-12-18 |
| 83378 |
cas:2226472-28-0 ，DBCO-PEG4-Val-Cit-PAB-PNP，二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
105 |
kx |
2024-12-18 |
| 83379 |
FA-PEG-DOTA 叶酸-聚乙二醇-DOTA |
94 |
h |
2024-12-18 |
| 83380 |
OA-PEG5烷基链定制 |
141 |
zyl |
2024-12-18 |
| 83381 |
共载SS31肽和胰岛素的脂质体纳米粒,DPS@INS,NPs,脂质体纳米载体定制服务 |
145 |
axc |
2024-12-18 |
| 83382 |
DOTA-PEG27-Cys-VS |
111 |
h |
2024-12-18 |
| 83383 |
cas:1613321-01-9 ，6-Azidohexanoyl-Val-Cit-PAB，6-叠氮己酰-VAL-CIT-PAB |
101 |
kx |
2024-12-18 |
| 83384 |
MPA-PEG4-GB-6的功能与应用 |
169 |
zyl |
2024-12-18 |
| 83385 |
DOTA-PEG-GA DOTA-聚乙二醇-甘草次酸 |
95 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询